MEDA - Misplaced Pages

This is an old revision of this page, as edited by Beetstra (talk | contribs) at 13:37, 24 February 2011 (Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: KEGG.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 13:37, 24 February 2011 by Beetstra (talk | contribs) (Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: KEGG.)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

MEDA
Names

IUPAC name 1-(8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
Identifiers
CAS Number	23693-25-6
3D model (JSmol)	Interactive image
ChemSpider	24034
KEGG	D03376
PubChem CID	25798
InChI InChI=1S/C4H11NS.ClH/c1-5(2)3-4-6;/h6H,3-4H2,1-2H3;1HKey: NRVFDGZJTPCULU-UHFFFAOYSA-N InChI=1/C4H11NS.ClH/c1-5(2)3-4-6;/h6H,3-4H2,1-2H3;1HKey: NRVFDGZJTPCULU-UHFFFAOYAB
SMILES Cl.SCCN(C)C
Properties
Chemical formula	C₁₂H₁₇NO₃
Molar mass	223.268 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is ?) Infobox references

Chemical compound

MEDA, or 3-methoxy-4,5-ethylenedi oxy amphetamine, is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 200 mg, and the duration unknown. MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.

External links

This psychoactive drug-related article is a stub. You can help Misplaced Pages by expanding it.